Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its ... Even after a 11% gain to $3.32, this stock has a 52-week range of $1.29 to $3.65 and it has a market cap of $223 million. We would also …
If you want a Stock Review on CPRX, FLXN, SUPN, or AGN then come over to http://dailystocktracker.com/register/ …
sending the stock soaring to a high of $1.55 that day (up from $1.12 the day before). As of Oct. 12, CPRX closed at $1.26, up 0.8% ($0.01) on a volume of 853,055 shares. Its 52-week range is $0.51 to $3.55. The company has a market cap of …
Catalyst Pharmaceuticals, Inc. CPRX is expected to report third-quarter 2017 results ... conclusively show an earnings beat for Catalyst this quarter. This is because a stock needs to have both — a positive Earnings ESP and a Zacks …
Yahoo!2mon
Catalyst Pharmaceuticals, Inc. CPRX announced positive top-line results from a second ... So far this year, Catalyst Pharma’s shares have outperformed the industry. The stock has surged 243.8% compared with the industry’s gain of …
Catalyst Pharmaceuticals, Inc. CPRX is expected to report first-quarter 2017 results on May 11. Last quarter, the company recorded a positive earnings surprise of 16.67%. Also, it topped expectations in all of the last four quarters with average …